Mutual Pharmaceutical Company Filed Counter Suit Against Adams Respiratory Therapeutics on Guaifenesin Case
URL Mutual Pharmaceutical Company, Inc. (Mutual) filed a counter suit against Adams Respiratory Therapeutics (Adams) on antitrust, tortious interference and unfair competition grounds.
The counter suit is a response to the filed lawsuits by Adams against Mutual in New Jersey and Pennsylvania alleging patent infringement after the company filed an Abbreviated New Drug Application (ANDA) with the USFDA for guaifenesin extended- release tablets, 600 mg and 1200 mg.
Mutual has already responded to the Find more details from the press release.
Comment Preview